Compatibility of hypokalaemia caused by low-dose prednisolone plus abiraterone acetate therapy for metastatic castration-resistant prostate cancer

• Main Authors: Shota Torii (Author), Aya Torii-Goto (Author), Tamaki Tanizawa (Author), Takashi Sakakibara (Author), Ryosuke Oguri (Author), Haruka Nagase (Author), Yuri Nakao (Author), Tomoyuki Hirashita (Author), Kuniaki Tanaka (Author), Norio Takimoto (Author), Takahiro Hayashi (Author)
• Format: Book
• Published: BMC, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background This study aimed to investigate the relationship between low-dose prednisolone (PSL) and the incidence of hypokalaemia at abiraterone acetate (abiraterone) plus PSL combination therapy targeting Japanese patients with metastatic castration-resistant prostate cancer (mCRPC). Metho...